Novartis Beats Failure-To-Warn Suit Over Zometa, Jury Rules

Law360, New York (June 26, 2013, 10:43 PM EDT) -- Novartis Pharmaceuticals Corp. defeated a cancer patient’s claims that she suffered a jaw disease after taking its cancer therapy drug Zometa when a California federal jury found that the drugmaker was not liable for failure to warn of such side effects. 

The jury verdict caps a trial that began June 10, with U.S. District Judge Jed Rakoff handing a final judgment Tuesday releasing Novartis from all claims by plaintiff Chris Hill. Initially bringing her suit in California state court in 2006, Hill had claimed she developed...
To view the full article, register now.